Gilead Sciences (GILD) Stock Price, Quote, News & History | Benzinga

Gilead Sciences Inc (GILD) Stock Price, Quote, News & History

GILDNASDAQ

Trade with Public

Trade with Public

$129.31

-1.55-1.18%

At close: Jul 24, 5:00 PM EST

$129.98

0.670.52%

After Hours: 6:02 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Dividends Compare Options Stock Report

Key Statistics

Open

$130.93

Close

$129.31

Volume / Avg.

5.53M / 7.51M

Day Range

$129.04 - $131.65

52 Wk Range

108.46 - 157.29

Market Cap

$161.38B

P/E Ratio

17.80

Dividend Yield

2.51%

Exchange

NASDAQ

RSI

48

Short Interest

2.05%

Days to Cover

2.66

Recent Gilead Sciences, Inc News

Two Years to Build or Pay 200% — Which US Pharma Stocks Win?

Trump sets a 2-year ultimatum for generic drugmakers to reshore U.S. production or face tariffs up to 200%.

Stjepan Kalinic

Gilead, Merck Advance Potential Blockbuster Weekly HIV Pill

Gilead & Merck Phase 3 data shows once-weekly ISL/LEN matches daily HIV meds in viral suppression through 48 weeks.

Vandana Singh

Kalshi Will Let Traders Bet on FDA Drug Approvals Despite Critics' Insider Trading Warnings

Kalshi is expanding into biotech with contracts on FDA drug approvals from Sanofi and Gilead, as critics warn the wagers invite insider trading.

Daragh Thomas

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

10.81B

Investing Cash Flow (TTM)

-2.61B

Financing Cash Flow (TTM)

-8.56B

Free Cash Flow (TTM)

10.23B

Capital Expenditure (TTM)

-576.00M

Net Change in Cash (TTM)

-360.00M

Analyst Trends and Forecast

1

Mar

2

Apr

2

May

1

Jun

4

1

Jul

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.4

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$175.08B

PE Ratio (TTM)

17.80

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

5.52

PB Ratio (TTM)

6.91

Earnings Yield % (TTM)

5.62%

Earnings Yield % (FWD)

-0.55%

EV / EBITDA (TTM)

12.22

Price / EBITDA (TTM)

11.33

Price / Free Cash Flow (TTM)

16.04

Book Value / Share

$18.94

Company Debt

Total Debt

$22.17B

LT Debt

$20.86B

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$2.79B

Total Cash

$7.63B

Debt to Equity

0.94

Issuance of Debt (TTM)

-$2.79B

Repayment of Debt (TTM)

-$2.79B

Key Statistics

Open

$130.93

Close

$129.31

Volume / Avg.

5.53M / 7.51M

Day Range

$129.04 - $131.65

52 Wk Range

108.46 - 157.29

Market Cap

$161.38B

P/E Ratio

17.80

Dividend Yield

2.51%

Exchange

NASDAQ

RSI

48

Short Interest

2.05%

Days to Cover

2.66

About

Sector

Health Care

Industry

Biotechnology

Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Soval...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

Q

How do I buy Gilead Sciences (GILD) stock?

A

You can purchase shares of Gilead Sciences (NASDAQ:GILD) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Gilead Sciences (GILD) competitors?

A

There are no as such competitors for Gilead Sciences.

Q

What is the forecast, or price target, for Gilead Sciences (GILD) stock?

A

Gilead Sciences has a consensus price target of $134.29.

Q

What is the current price for Gilead Sciences (GILD)?

A

The stock price for Gilead Sciences (NASDAQ: GILD) is $129.98 last updated July 24, 2026 at 6:02 PM EDT.

Q

Does Gilead Sciences (GILD) pay a dividend?

A

There are no upcoming dividends for Gilead Sciences.

Q

When is Gilead Sciences (NASDAQ:GILD) reporting earnings?

A

Gilead Sciences does not have any upcoming earnings scheduled.

Q

Is Gilead Sciences (GILD) going to split?

A

There is no upcoming split for Gilead Sciences.

Q

What sector and industry does Gilead Sciences (GILD) operate in?

A

Gilead Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.